| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | W P Arend | |
| P2860 | cites work | Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor | Q24294731 |
| Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein | Q24296266 | ||
| Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction | Q24314529 | ||
| Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor | Q24318599 | ||
| Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism | Q28571336 | ||
| Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist | Q33836551 | ||
| Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist | Q34251859 | ||
| Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis | Q34260899 | ||
| Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s) | Q34544134 | ||
| Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody | Q36360942 | ||
| A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice | Q36360996 | ||
| Interleukin-1 and interleukin-1 antagonism | Q37081535 | ||
| Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis | Q37456977 | ||
| cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium | Q37494553 | ||
| Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis | Q37908865 | ||
| Native interleukin 1 inhibitors | Q38255319 | ||
| Purification and characterization of interleukin 1 receptor level antagonist proteins from THP-1 cells | Q38339615 | ||
| An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. | Q40153016 | ||
| Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever | Q40752402 | ||
| Induction of plasma inhibitors of interleukin 1 and TNF-alpha activity by endotoxin administration to normal humans | Q40756925 | ||
| Human granulocyte-macrophage colony-stimulating factor plus phorbol myristate acetate stimulate a promyelocytic cell line to produce an IL-1 inhibitor | Q40760248 | ||
| Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. | Q40764690 | ||
| A human IL-1 alpha derivative which lacks prostaglandin E2 inducing activity and inhibits the activity of IL-1 through receptor competition | Q40767467 | ||
| Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis | Q40792142 | ||
| A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha. | Q40794428 | ||
| A urine inhibitor of interleukin 1 activity that blocks ligand binding. | Q40794456 | ||
| Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. | Q41152837 | ||
| Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages | Q41720046 | ||
| Production of a 26,000-dalton interleukin 1 inhibitor by human monocytes is regulated by granulocyte-macrophage colony-stimulating factor | Q41742952 | ||
| The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation | Q41835332 | ||
| C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis | Q43478050 | ||
| A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits | Q43740171 | ||
| Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. | Q44037744 | ||
| Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor | Q44598548 | ||
| Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β | Q58479946 | ||
| Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
| Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1–stimulated cartilage erosion and chondrocyte responsiveness | Q67897217 | ||
| Mouse IL-1 receptor antagonist protein. Molecular characterization, gene mapping, and expression of mRNA in vitro and in vivo | Q67899769 | ||
| IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors | Q67900835 | ||
| Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated | Q67902109 | ||
| IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently | Q67902224 | ||
| A point mutation uncouples human interleukin-1 beta biological activity and receptor binding | Q68413600 | ||
| Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production | Q68435194 | ||
| Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6 | Q68490165 | ||
| Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer | Q68568858 | ||
| Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals | Q68903017 | ||
| Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF | Q69171062 | ||
| A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets | Q93516981 | ||
| An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties | Q93519955 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 1445-51 | |
| P577 | publication date | 1991-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Interleukin 1 receptor antagonist. A new member of the interleukin 1 family | |
| P478 | volume | 88 |
| Q33824014 | "Inflammatory" cytokines: neuromodulators in normal brain? |
| Q40932806 | A review on the strategies for the development and application of new anti-arthritic agents |
| Q37083101 | Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder |
| Q34587471 | Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation |
| Q36379383 | Adipose targets for obesity drug development |
| Q42523327 | Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family |
| Q89554255 | Alternatively activated macrophages; a double-edged sword in allergic asthma |
| Q36837219 | An ex vivo method for studying inflammation in cynomolgus monkeys: analysis of interleukin-1 receptor antagonist |
| Q31089069 | Anakinra treatment of patients with rheumatoid arthritis |
| Q33578174 | Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis |
| Q36362566 | Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells |
| Q58844504 | Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility |
| Q72012561 | Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor α in the knee-joints of patients with rheumatoid arthritis |
| Q73800880 | Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis |
| Q37118553 | Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones |
| Q39936881 | Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction |
| Q41201773 | Biologic agents for the treatment of rheumatoid arthritis |
| Q34071296 | Biological role of interleukin 1 receptor antagonist isoforms |
| Q47972551 | Blockade of brain type II interleukin-1 receptors potentiates IL1beta-induced anorexia in mice. |
| Q50165542 | Blood cytokine levels rise even after minor surgical trauma |
| Q40147847 | Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes |
| Q37365015 | Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure. |
| Q37602716 | Cerebral ischemic damage in diabetes: an inflammatory perspective |
| Q54013178 | Characterization of a murine model of acute lung injury (ALI): a prominent role for interleukin-1. |
| Q72567614 | Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease |
| Q73268682 | Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma |
| Q40826895 | Cloning of canine IL-1ra, TNFR and TIMP-2. |
| Q47901523 | Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). |
| Q92422540 | Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model |
| Q44205828 | Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist |
| Q71687610 | Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice |
| Q72333296 | Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis |
| Q40793055 | Cyclosporin for inflammatory bowel disease: mechanisms and possible actions |
| Q36628232 | Cytokine changes in patients with heatstroke during pilgrimage to Makkah |
| Q41103809 | Cytokine expression by head and neck squamous cell carcinomas |
| Q33568552 | Cytokine inhibition in the treatment of COPD. |
| Q41209346 | Cytokine inhibitors in autoimmune disease |
| Q36479970 | Cytokine regulation of mucin secretion in a human middle ear epithelial model |
| Q40766809 | Cytokine technology in basic and applied research on the hematopoietic system |
| Q72023441 | Cytokines and Adherence Molecules Involved in Spontaneous Dendritic Cell‐Lymphocyte Clustering in Skin Afferent Lymph |
| Q57081397 | Cytokines and preterm labour |
| Q41165211 | Cytokines and production of surfactant components |
| Q41474260 | Cytokines and the hepatic acute phase response |
| Q40658354 | Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function |
| Q35556914 | Cytokines in inflammatory bowel disease |
| Q40896076 | Cytokines, sepsis and immunomodulation |
| Q36284578 | Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung |
| Q72678147 | Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID) |
| Q71120320 | Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia |
| Q54268444 | Differences of plasma IL-1 and TNF-α in healthy Chinese Population. |
| Q47355524 | Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats |
| Q40144803 | Differentiating Staphylococcus aureus from Escherichia coli mastitis: S. aureus triggers unbalanced immune-dampening and host cell invasion immediately after udder infection |
| Q36982003 | Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation |
| Q71868856 | Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes |
| Q70710585 | Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat |
| Q35552826 | Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. |
| Q31443523 | Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia |
| Q71449313 | Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia |
| Q33860266 | Endogenous inhibitory mechanisms in asthma |
| Q44569273 | Enhancement by neutrophils of collagen degradation by corneal fibroblasts |
| Q47919623 | Enzymatic amplification and expression of bovine interleukin-1 receptor antagonist cDNA. |
| Q36424417 | Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes |
| Q38507723 | Equivalence testing in microarray analysis: similarities in the transcriptome of human atherosclerotic and nonatherosclerotic macrophages. |
| Q50906970 | Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra. |
| Q40793877 | Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy |
| Q71692241 | Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa--implications for pathogenesis |
| Q41074875 | Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans |
| Q33601143 | Exercise attenuates neurological deficits by stimulating a critical HSP70/NF-κB/IL-6/synapsin I axis in traumatic brain injury rats |
| Q48854928 | Expression of interleukin-1 (IL-1) system genes in equine cumulus-oocyte complexes and influence of IL-1beta during in vitro maturation |
| Q36777053 | Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells |
| Q47742169 | Expression of the interleukin 1 receptor antagonist in the normal human cornea |
| Q41138260 | Extracellular matrix and lung inflammation |
| Q41484408 | Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature |
| Q38550768 | Food allergy, coeliac disease and chronic inflammatory bowel disease in man. |
| Q51473069 | Formation of complement split products and proinflammatory cytokines by reinfusion of shed autologous blood. |
| Q30855755 | Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer |
| Q36319054 | Genetic variation associated with preterm birth: a HuGE review |
| Q73677908 | HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo |
| Q41615513 | Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits |
| Q40913067 | IL-1beta increases intracellular calcium through an IL-1 type 1 receptor mediated mechanism in C6 astrocytic cells |
| Q43241239 | IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro |
| Q90121110 | IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis |
| Q48706259 | IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. |
| Q33247353 | Identification of multiple integrin beta1 homologs in zebrafish (Danio rerio) |
| Q40552988 | Identification, purification and characterization of a receptor for dengue virus-induced macrophage cytotoxin (CF2) from murine T cells |
| Q48368954 | Immune and endocrine regulation of food intake in sick animals |
| Q41101381 | Immunotherapy for sepsis |
| Q36928740 | In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. |
| Q41621992 | In vitro studies of glial cells: what can we learn about demyelinating diseases? |
| Q28570397 | In vivo IL-1beta-induced modulation of G-protein alphaO subunit subclass in the hypothalamic ventromedial nucleus: implications to IL-1beta-associated anorexia |
| Q41969880 | In vivo retention and bioactivity of IL-1ra microspheres in the rat intervertebral disc: a preliminary investigation. |
| Q37123923 | Increased Fanconi C expression contributes to the emergency granulopoiesis response |
| Q38817383 | Inflammatory Mediators and Oxidative Stress in Animals Subjected to Smoke Inhalation: A Systematic Review |
| Q41457693 | Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta |
| Q67924873 | Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells |
| Q40837755 | Inhibitory cytokines in asthma |
| Q37755268 | Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis |
| Q41109548 | Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. |
| Q36361487 | Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo |
| Q35609266 | Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis |
| Q73539375 | Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis |
| Q35841729 | Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury |
| Q74530390 | Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes |
| Q33493710 | Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits |
| Q24806748 | Interleukin-1 (IL-1) system gene expression in granulosa cells: kinetics during terminal preovulatory follicle maturation in the mare |
| Q35117155 | Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor |
| Q72037366 | Interleukin-1 Receptor Antagonist Suppresses Contact Hypersensitivity |
| Q37272140 | Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID) |
| Q40415846 | Interleukin-1 in crescentic glomerulonephritis |
| Q34354989 | Interleukin-1 receptor antagonist |
| Q77118254 | Interleukin-1 receptor antagonist |
| Q48274408 | Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease |
| Q35824596 | Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice |
| Q28566186 | Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats |
| Q34452084 | Interleukin-1 receptor antagonist as therapy for inflammatory disorders |
| Q41088177 | Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium |
| Q34143196 | Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats |
| Q53297543 | Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer |
| Q40713375 | Interleukin-1 receptor antagonist in newborn babies and pregnant women |
| Q72963420 | Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate |
| Q41285681 | Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis |
| Q51657268 | Interleukin-10 gene -627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma. |
| Q64944469 | Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS. |
| Q40646423 | Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems and |
| Q41702494 | Interleukin-1beta sensitizes abdominal visceral afferents of cats to ischaemia and histamine |
| Q48478886 | Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia |
| Q42500213 | Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells |
| Q39811703 | Interleukin-4 inhibits secretion of interleukin-1beta in the response of human cells to mycobacterial heat shock proteins. |
| Q41573958 | Interleukin‐1 ‐induced expression of nitric oxide synthase in insulin‐producing cells is preceded by c‐fos induction and depends on gene transcription and protein synthesis |
| Q37369026 | Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth |
| Q34544863 | Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes |
| Q41671662 | Is there clinical, epidemiological and molecular evidence for two forms of Crohn's disease? |
| Q40569186 | Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections |
| Q33618092 | Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis |
| Q38336752 | Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs |
| Q67554442 | Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell |
| Q35821863 | Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist |
| Q40726535 | Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation. |
| Q36744464 | Microarray analysis of host gene expression for comparison between naïve and HSV-1 latent rabbit trigeminal ganglia. |
| Q41330304 | Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist |
| Q42642462 | Molecular cloning and functional expression of bottle-nosed dolphin (Tursiops truncatus) interleukin-1 receptor antagonist |
| Q40791025 | Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. |
| Q35701721 | Multiple organ failure. Pathophysiology and potential future therapy |
| Q98177717 | NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword |
| Q34432736 | Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach. |
| Q41205044 | Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop |
| Q36838556 | Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin |
| Q44494215 | Normal and premature rupture of fetal membranes at term delivery differ in regional chemotactic activity and related chemokine/cytokine production |
| Q38247119 | Novel investigational therapies for atopic dermatitis |
| Q34192949 | Novel production of interleukin-1 receptor antagonist peptides in normal human cornea |
| Q35220874 | Ocular fibroblast diversity: implications for inflammation and ocular wound healing |
| Q42473657 | Ovarian interleukin-1 receptor antagonist in rats: gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action |
| Q45739454 | Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes |
| Q41380820 | Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. |
| Q48537911 | Peri-OVLT E-series prostaglandins and core temperature do not increase after intravenous IL-1beta in pregnant rats |
| Q72303278 | Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta |
| Q72407141 | Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss |
| Q92447263 | Pharmacokinetics of Anakinra in Subjects of Heavier vs. Lighter Body Weights |
| Q36225249 | Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate |
| Q40677100 | Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients |
| Q40679690 | Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia |
| Q53385157 | Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. |
| Q53090585 | Postorthodontic external root resorption is associated with IL1 receptor antagonist gene variations. |
| Q41051525 | Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure |
| Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
| Q72351143 | Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction |
| Q48539185 | Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables |
| Q36263101 | Predisposition of genetic polymorphism with the risk of urolithiasis |
| Q40480466 | Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. |
| Q33616880 | Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I |
| Q34036124 | Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine |
| Q78016155 | Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors |
| Q77616409 | Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention |
| Q33903615 | Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice |
| Q89688049 | Protective role of diosgenin against hyperglycaemia-mediated cerebral ischemic brain injury in zebrafish model of type II diabetes mellitus |
| Q35277314 | Recent advances in asthma |
| Q34085870 | Reciprocal interactions between the neuroendocrine and immune systems during inflammation |
| Q28579434 | Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid |
| Q40740265 | Regulation of transcription of the intracellular interleukin-1 receptor antagonist gene by AP-1 in mouse carcinoma cells |
| Q37352036 | Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury. |
| Q81164940 | Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection |
| Q74169178 | Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis |
| Q35383409 | Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques |
| Q35071362 | Role of cytokine signaling in group B Streptococcus-stimulated expression of human beta defensin-2 in human extraplacental membranes |
| Q33617636 | Role of cytokines and their inhibitors in acute pancreatitis |
| Q90216405 | Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study |
| Q40656511 | Soluble receptors for cytokines and growth factors: generation and biological function |
| Q41275832 | Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. |
| Q71996875 | Stability and compatibility of anakinra with intravenous cimetidine hydrochloride or famotidine in 09% sodium chloride injection |
| Q41763871 | Stretch and/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade. |
| Q34164095 | Stroke, IL-1ra, IL1RN, infection and outcome |
| Q43441755 | Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling |
| Q35128911 | Such stuff as dreams are made on: mediator-directed therapy in sepsis |
| Q64056874 | The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes |
| Q34576944 | The aged epidermal permeability barrier: basis for functional abnormalities |
| Q48134745 | The detection of a synthetic Interleukin-1 receptor antagonist peptide in a seized product from a racing stable |
| Q56878319 | The dynamic responses of pro-inflammatory and anti-inflammatory cytokines of human mononuclear cells induced by uromodulin |
| Q44459374 | The gene expression analysis of paracrine/autocrine factors in patients with spermatogenetic failure compared with normal spermatogenesis. |
| Q42669055 | The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction |
| Q36617109 | The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness |
| Q40374245 | The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats |
| Q73865604 | The interleukin-1 system in gestational tissues at term: effect of labour |
| Q35864265 | The local inflammatory responses to infection of the peritoneal cavity in humans: their regulation by cytokines, macrophages, and other leukocytes |
| Q61845787 | The natural interleukin-1 receptor antagonist in term and preterm parturition |
| Q74485778 | The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene |
| Q40667669 | The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection |
| Q35233166 | The role of cytokines and their inhibitors in arthritis |
| Q64915337 | The role of interleukin-1 in general pathology. |
| Q38006302 | The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases |
| Q36536313 | Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines |
| Q35757433 | Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells |
| Q41267810 | Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. |
| Q46224777 | Treatment of knee osteoarthritis with Orthokine-derived autologous conditioned serum |
| Q36057492 | Trial Watch: Immunostimulatory cytokines |
| Q33905066 | Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets |
| Q34160907 | Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion |
| Q73100027 | Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients |
Search more.